Nanotechnology is reshaping periodontal diagnostics, drug delivery, anti-infective strategies, and tissue regeneration. Engineered nanoparticles (NPs), nanofibers, and nano-modified biomaterials can localize therapeutics within periodontal pockets, disrupt biofilms, modulate inflammation, and enhance regeneration through spatiotemporally controlled release of bioactive agents. While preclinical and early clinical data are encouraging-particularly for antimicrobial NPs, nano-hydroxyapatite (nHA) grafts, and nano-enabled membranes-questions remain about long-term safety, standardization, and regulatory pathways.1
1*Dr. Vinu Priya P., 2Dr. Jaishree Tukaram Kshirsagar, 3Dr. Mohamed Riyaz J. (Wed,) studied this question.